Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Pediatric Chronic Anemia Workup

  • Author: Susumu Inoue, MD; Chief Editor: Max J Coppes, MD, PhD, MBA  more...
 
Updated: Apr 12, 2016
 

Approach Considerations

To evaluate anemia, obtain initial laboratory tests, including a complete blood count (CBC), a reticulocyte count, and a review of the peripheral smear. Imaging studies can play a role in the diagnosis of underlying disease, while bone marrow aspiration and biopsy can be used to identify the presence of tumor cells and determine cellular morphology.

Next

CBC Count

Note different normal ranges for different ages. Some laboratories provide only a uniform reference range for the entire pediatric age group and not for specific age groups. Interpret this carefully to avoid misdiagnosis. Hemoglobin and hematocrit levels can be used interchangeably, depending on professional preference and familiarity. Essentially, the hematocrit level is 3 times the hemoglobin value.

Red cell indices are quite informative, particularly mean corpuscular volume (MCV), mean corpuscular hemoglobin concentration (MCHC), and red cell distribution width (RDW).

Note that reference ranges for these parameters also vary with age. Because of this, the author suggests using the MCV cut-off point of 70 plus age in years for patients aged 7 years or younger (eg, MCV < 72 is abnormal for a patient aged 2 y).

A high RDW (eg, ≥19-20) with microcytic picture is most often indicative of iron deficiency anemia in the pediatric population. The RDW is also very high in anemia with reticulocytosis, including sickle cell disease.

Macrocytosis suggests folate/vitamin B-12 deficiency; however, nutritional deficiencies of these vitamins are rare. Diamond-Blackfan anemia, aplastic anemia, and myelodysplastic syndrome often present with macrocytic anemia. Patients with sickle cell anemia who have been on hydroxyurea also show macrocytosis.

Note that in newborns, MCV is physiologically in the range of 120-102. Beyond the immediate newborn period, MCV exceeding 98 is very uncommon in children; if the volume exceeds 98, it usually indicates a serious hematologic problem, such as myelodysplastic syndrome, leukemia, aplastic anemia, Diamond-Blackfan anemia, or metabolic disorder.

In most, but not all cases of HS, the MCHC exceeds the upper limit of the reference range.

Previous
Next

Reticulocyte Count

Reticulocytes are immature, nonnucleated RBCs. An increase in the reticulocyte count (in particular, the absolute reticulocyte count) indicates active erythropoiesis.

The relative reticulocyte count is useful in determining whether anemia is caused by decreased production, increased destruction, or loss of RBCs. An elevated number of reticulocytes is (eventually) observed in individuals with anemia caused by hemolysis or blood loss; note that the absence of reticulocytosis may simply reflect a lag in the response to the acute onset of anemia.

The term reticulocyte count is often inaccurately used to refer to the percentage of reticulocytes, a value that must be interpreted in light of the degree of anemia. Thus, a finding of 2-3% reticulocytes (vs the reference value of approximately 1%) in a patient in whom the hemoglobin level is only one third to one half of reference range does not indicate a reticulocyte response.

Some clinicians prefer to use either the absolute number of reticulocytes/μL of blood or a reticulocyte percentage that is corrected for the degree of anemia. The corrected reticulocyte count equals (patient hematocrit)/(reference range hematocrit) multiplied by the percentage reticulocyte count.

Previous
Next

Peripheral Smear

Examination of the peripheral smear is particularly helpful in normocytic anemia. The red cell morphology itself is quite often diagnostic. The following are examples of abnormal cell morphology in normocytic picture:

  • Ghost, bite, blister, or helmet cells (G-6-PD), as depicted in the image below
    Blood smear from a black male with glucose-6-phosp Blood smear from a black male with glucose-6-phosphate dehydrogenase (G-6-PD) deficiency that resulted in acute hemolysis. Note blister (helmet or bite) cells and very dense spherocytic cells. The blood smear is virtually pathognomic of this disorder.
  • Spherocytes (HS, autoimmune hemolytic anemia, ABO hemolytic anemia in newborns), as depicted in the image below
    Blood smear of hereditary spherocytosis (HS). Note Blood smear of hereditary spherocytosis (HS). Note many spherocytic cells. Not all patients with HS are anemic.
  • Target cells (hemoglobin C, liver disease, thalassemia), as depicted in the image below
    Blood smear of hemoglobin C trait. Note numerous t Blood smear of hemoglobin C trait. Note numerous target cells. Target cells are a characteristic of this hemoglobinopathy. The trait patient has no anemia. Target cells are also seen in patients with iron deficiency anemia, thalassemia, sickle cell disease, and liver disease.
  • Sickle-shaped cells (drepanocytes) (sickle cell disease), as depicted in the image below
    Blood smear of a patient with homozygous sickle ce Blood smear of a patient with homozygous sickle cell disease. Note several sickle cells, a nucleated RBC, and a red cell with Howell-Jolly body (indicated by an arrow), evidence of functional asplenia.
  • Schistocytes or fragmented cells (microangiopathic hemolytic anemia), as depicted in the image below
    A blood smear showing a few schistocytes. This pat A blood smear showing a few schistocytes. This patient had Kaposi type hemangioendothelioma with periodic microangiopathic hemolysis and disseminated coagulopathy (Kasabach-Merritt phenomenon).
  • Stippled RBCs, basophilic stippling (in all conditions with increased reticulocyte count and in lead poisoning and 5' nucleotidase deficiency), as depicted in the image below
    A blood smear of a patient with beta thalassemia t A blood smear of a patient with beta thalassemia trait. Note red cells pointed by arrows. Multiple bluish dots in the cells are called basophilic stipplings and consist of aggregated ribosomes. They are often present in immature red cells such as reticulocytes.
  • Increased polychromasia (reticulocytosis)

Normal RBC morphology does not exclude hemolysis.

Previous
Next

Additional Laboratory Tests

Additional laboratory tests that may be indicated in the diagnosis and treatment of patients with acute anemia include the following:

  • Bilirubin level, lactate dehydrogenase (LDH) level (hemolytic anemia), and serum haptoglobulin level (decreased or none in chronic hemolytic anemia)
  • Direct antiglobulin or Coombs test (autoimmune hemolytic anemia)
  • Hemoglobin electrophoresis (hemoglobinopathies)
  • Hemoglobin A2 quantitation (β-thalassemia trait, increased above 3.5%)
  • Red cell enzyme studies (eg, G-6-PD, pyruvate kinase), osmotic fragility (spherocytosis) (G-6-PD-deficient red cells may show a normal G-6-PD screening result in the presence of reticulocytosis, and therefore, actual enzyme quantitation is strongly recommended; a normal enzyme level in the presence of reticulocytosis indicates a deficiency)
  • Iron, total iron-binding capacity, and ferritin levels (iron deficiency anemia); soluble (serum) transferrin receptor (differentiation of iron deficiency anemia [increased] from anemia of chronic disease [normal]); free erythrocyte protoporphyrin (FEP) or zinc erythrocyte protoporphyrin (for partially treated iron-deficiency anemia), increased in the presence of normal serum iron)
  • Stool for occult blood (examine at least 3 specimens; in the presence of demonstrated intestinal blood loss, any given stool specimen finding may be negative, which is why multiple specimens are required before one can conclude a negative finding.)
  • Folate and vitamin B-12 levels (macrocytic/megaloblastic anemia)
  • Blood typing and cross matching to assess possible isoimmune anemia in a neonate and to prepare for transfusion
  • Viral antibody titers and viral DNA by PCR assay (eg, Epstein-Barr virus, cytomegalovirus, parvovirus B19, HIV)
  • Urinalysis and blood urea nitrogen (BUN)/creatinine levels to assess renal function
  • Thyroxine (T 4)/thyroid-stimulating hormone (TSH) levels to exclude hypothyroidism
Previous
Next

Radiography and Echocardiography

Chest radiography and echocardiography are indicated for suspected congestive heart failure.

Skull films and films of the hands and wrists may show expanded marrow space. Spine radiography may reveal a paraspinal (vertebral) pseudotumor due to marked expansion of the bone marrow (usually in thalassemia major).

Previous
Next

Ultrasonography and CT Scanning

In cases of suspected hypersplenism, using ultrasonography or computed tomography (CT) scanning to detect a large spleen is not recommended. If a thorough physical examination does not detect a palpable spleen, hypersplenism is not a likely diagnosis.

Ultrasonography of the gallbladder for the presence of gallstones in patients with chronic hemolytic anemia may be valuable if the patient has recurrent abdominal pain. Abdominal pain due to gallstones in children is not always in the right upper quadrant. The author has received reports of left upper quadrant pain in children with gallstones that subsided after cholecystectomy.

Previous
Next

Additional Studies

Other imaging studies are indicated to detect underlying pathology, including the following:

  • Magnetic resonance imaging (MRI) of bones for suspected osteomyelitis
  • Positron emission tomography (PET) scanning for suspected lymphoma (Hodgkin lymphoma and non-Hodgkin lymphoma)
  • Endoscopy for GI ulcers, inflammatory bowel disease, celiac disease

Exclude impending high-output congestive heart failure using electrocardiography (ECG).

Specimens from bone marrow aspiration and biopsy are often essential in helping to characterize overall cellularity, the presence or absence of tumor cells, the morphology and maturation of red cell precursors, and the presence or absence of stainable iron.

Bone marrow aspiration and biopsy can be used to rule out leukemia, aplastic anemia, tumor cells in the marrow (such as neuroblastoma), megaloblastosis, marrow dysplasia, and hemophagocytosis. It can also be employed in detection of the absence of 1 cell line due to pure red cell aplasia or parvovirus infection.

Previous
 
 
Contributor Information and Disclosures
Author

Susumu Inoue, MD Professor of Pediatrics and Human Development, Michigan State University College of Human Medicine; Clinical Professor of Pediatrics, Wayne State University School of Medicine; Director of Pediatric Hematology/Oncology, Associate Director of Pediatric Education, Department of Pediatrics, Hurley Medical Center

Susumu Inoue, MD is a member of the following medical societies: American Academy of Pediatrics, American Society of Clinical Oncology, American Society of Hematology, American Society of Pediatric Hematology/Oncology, Society for Pediatric Research

Disclosure: Nothing to disclose.

Coauthor(s)

John T Truman, MD, MPH Professor Emeritus of Clinical Pediatrics, Columbia University College of Physicians and Surgeons

John T Truman, MD, MPH is a member of the following medical societies: American Academy of Pediatrics, American Association for the History of Medicine, American Society of Pediatric Nephrology, New York Academy of Medicine

Disclosure: Nothing to disclose.

Margaret T Lee, MD Associate Professor, Department of Pediatrics, Division of Pediatric Hematology/Oncology/SCT, Children's Hospital of New York, Columbia University College of Physicians and Surgeons

Margaret T Lee, MD is a member of the following medical societies: American Society of Hematology

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Steven K Bergstrom, MD Department of Pediatrics, Division of Hematology-Oncology, Kaiser Permanente Medical Center of Oakland

Steven K Bergstrom, MD is a member of the following medical societies: Alpha Omega Alpha, Children's Oncology Group, American Society of Clinical Oncology, International Society for Experimental Hematology, American Society of Hematology, American Society of Pediatric Hematology/Oncology

Disclosure: Nothing to disclose.

Chief Editor

Max J Coppes, MD, PhD, MBA Executive Vice President, Chief Medical and Academic Officer, Renown Heath

Max J Coppes, MD, PhD, MBA is a member of the following medical societies: American College of Healthcare Executives, American Society of Pediatric Hematology/Oncology, Society for Pediatric Research

Disclosure: Nothing to disclose.

Additional Contributors

J Martin Johnston, MD Associate Professor of Pediatrics, Mercer University School of Medicine; Director of Hematology/Oncology, The Children's Hospital at Memorial University Medical Center; Consulting Oncologist/Hematologist, St Damien's Pediatric Hospital

J Martin Johnston, MD is a member of the following medical societies: American Academy of Pediatrics, American Society of Pediatric Hematology/Oncology, International Society of Paediatric Oncology

Disclosure: Nothing to disclose.

References
  1. Dowling MM, Quinn CT, Plumb P, Rogers ZR, Rollins NK, Koral K. Acute silent cerebral ischemia and infarction during acute anemia in children with and without sickle cell disease. Blood. 2012 Nov 8. 120(19):3891-7. [Medline].

  2. Baker C, Grant AM, George MG, Grosse SD, Adamkiewicz TV. Contribution of Sickle Cell Disease to the Pediatric Stroke Burden Among Hospital Discharges of African-Americans-United States, 1997-2012. Pediatr Blood Cancer. 2015 Dec. 62 (12):2076-81. [Medline].

  3. Skeppner G, Kreuger A, Elinder G. Transient erythroblastopenia of childhood: prospective study of 10 patients with special reference to viral infections. J Pediatr Hematol Oncol. 2002 May. 24(4):294-8. [Medline].

  4. Penchansky L, Jordan JA. Transient erythroblastopenia of childhood associated with human herpesvirus type 6, variant B. Am J Clin Pathol. 1997 Aug. 108(2):127-32. [Medline].

  5. Prassouli A, Papadakis V, Tsakris A, Stefanaki K, Garoufi A, Haidas S. Classic transient erythroblastopenia of childhood with human parvovirus B19 genome detection in the blood and bone marrow. J Pediatr Hematol Oncol. 2005 Jun. 27(6):333-6. [Medline].

  6. Iolascon A, Camaschella C, Pospisilova D, Piscopo C, Tchernia G, Beaumont C. Natural history of recessive inheritance of DMT1 mutations. J Pediatr. 2008 Jan. 152(1):136-9. [Medline].

  7. Global Burden of Disease Pediatrics Collaboration, Kyu HH, Pinho C, et al. Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Burden of Disease 2013 Study. JAMA Pediatr. 2016 Mar 1. 170 (3):267-87. [Medline].

  8. Henderson S, Timbs A, McCarthy J, Gallienne A, Van Mourik M, Masters G. Incidence of haemoglobinopathies in various populations - the impact of immigration. Clin Biochem. 2009 Dec. 42(18):1745-56. [Medline].

  9. Williams TN, Weatherall DJ. World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb Perspect Med. 2012 Sep. 2(9):a011692. [Medline].

  10. Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010 Jun 3. 115(22):4331-6. [Medline].

  11. Baker RD, Greer FR. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). Pediatrics. 2010 Nov. 126(5):1040-50. [Medline].

  12. Lozoff B, Castillo M, Clark KM, Smith JB. Iron-fortified vs low-iron infant formula: developmental outcome at 10 years. Arch Pediatr Adolesc Med. 2012 Mar. 166(3):208-15. [Medline]. [Full Text].

  13. Wiseman DH, May A, Jolles S, et al. A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD). Blood. 2013 Jul 4. 122 (1):112-23. [Medline]. [Full Text].

  14. Iolascon A, De Falco L. Mutations in the gene encoding DMT1: clinical presentation and treatment. Semin Hematol. 2009 Oct. 46(4):358-70. [Medline].

  15. Finberg KE. Iron-refractory iron deficiency anemia. Semin Hematol. 2009 Oct. 46(4):378-86. [Medline].

 
Previous
Next
 
Blood smear from a black male with glucose-6-phosphate dehydrogenase (G-6-PD) deficiency that resulted in acute hemolysis. Note blister (helmet or bite) cells and very dense spherocytic cells. The blood smear is virtually pathognomic of this disorder.
Blood smear of hereditary spherocytosis (HS). Note many spherocytic cells. Not all patients with HS are anemic.
Blood smear of hemoglobin C trait. Note numerous target cells. Target cells are a characteristic of this hemoglobinopathy. The trait patient has no anemia. Target cells are also seen in patients with iron deficiency anemia, thalassemia, sickle cell disease, and liver disease.
Blood smear of a patient with homozygous sickle cell disease. Note several sickle cells, a nucleated RBC, and a red cell with Howell-Jolly body (indicated by an arrow), evidence of functional asplenia.
A blood smear showing a few schistocytes. This patient had Kaposi type hemangioendothelioma with periodic microangiopathic hemolysis and disseminated coagulopathy (Kasabach-Merritt phenomenon).
A blood smear of a patient with beta thalassemia trait. Note red cells pointed by arrows. Multiple bluish dots in the cells are called basophilic stipplings and consist of aggregated ribosomes. They are often present in immature red cells such as reticulocytes.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.